EbsArgent targets urinary tract infections, with early indications of efficacy against many species of multidrug-resistant bacteria STOCKHOLM, Oct. 30, 2024 /PRNewswire/ — Thioredoxin Systems AB (TXN Systems), a pharmaceutical company developing a first-in-class antibiotic for…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.